Loss of BAP1 is implicated in a distinct subset of cancers like development of mesothelioma [5, 6], uveal and cutaneous melanoma [7, 8], clear cell renal cell carcinoma [9, 10] and bladder cancer [11]. This evidence concerns the gene BAP1 and clear cell renal carcinoma.